After this webinar attendees will be able to answer:

• What is the practical difference between the HHS-OIG List of Excluded Individuals/Entities (LEIE) and the CMS Preclusion List, and why does treating them as the same list create compliance gaps?
• Who should be screened before hiring or contracting, and which employees, contractors, vendors, staffing personnel, billing partners, or other downstream relationships may create Federal health care program exposure?
• How often should an organization screen the LEIE, and why does OIG state that monthly screening best minimizes potential overpayment and civil monetary penalty exposure?
• Which screening records should be retained so the organization can show what was checked, when it was checked, who performed the review, and how possible matches were resolved?
• When are state Medicaid exclusion lists or other databases relevant, and why should organizations avoid assuming that one federal database satisfies every federal, state, payer, or contractual requirement?
• What happens when a provider, supplier, or prescriber appears on the CMS Preclusion List, and how can that affect Medicare Advantage payment or Part D pharmacy claims?
• How should compliance, HR, credentialing, procurement, billing, and vendor-management teams divide responsibility, and what should happen when a potential excluded or precluded individual is identified?

Webinar details:

Exclusion screening is not merely a credentialing task. For organizations that receive Federal health care program reimbursement, an overlooked excluded individual or entity can become a compliance, repayment, contracting, and audit problem.

This 60-minute program focuses on the difference between the HHS-OIG LEIE and the CMS Preclusion List and on the screening controls healthcare organizations should have around employees, contractors, vendors, prescribers, billing partners, and other relationships that can affect federally reimbursed services.

The OIG LEIE identifies individuals and entities excluded from participation in Federal health care programs. OIG explains that payment generally may not be made by Federal health care programs for items or services furnished, ordered, or prescribed by excluded parties. Healthcare entities that employ or contract with excluded persons may face civil monetary penalty and overpayment exposure when federally reimbursed items or services are involved.

The CMS Preclusion List serves a different purpose. It identifies certain providers and prescribers that are precluded from receiving payment for Medicare Advantage items and services or for Part D drugs furnished or prescribed to Medicare beneficiaries. Medicare Advantage plans and Part D sponsors use the list for payment denial and claim-rejection requirements.

For compliance officers and auditors, the central issue is whether the organization has a repeatable screening process that can be demonstrated after the fact. A defensible process should address who is screened, which source is used, how often screening occurs, how identity matches are verified, how state or contractual requirements are handled, and how evidence of the review is retained.

For CEOs, CFOs, billing leaders, and operations executives, the issue is financial as well as regulatory. Screening failures can create avoidable repayment exposure, disrupt claims, trigger internal investigations, and require significant retrospective review.

Important Current Update - September 2026

OIG exclusion enforcement remains active in 2026. In late August alone, OIG published multiple self-disclosure settlements involving allegations that healthcare organizations employed excluded individuals. These included a settlement of approximately $525,883 involving Liberty County Hospital District No. 1 and PF Carthage SNF Ops, along with other August settlements involving excluded employees.

The LEIE itself remains a live monthly screening source. OIG states that exclusion information is updated by the 10th of each month. As of September 10, 2026, OIG had posted the August 2026 updated LEIE database along with August exclusions and reinstatements.

This creates a clear operational lesson: a screening result from several months ago does not establish a person's current status. Organizations need a documented process for recurring checks and for resolving possible matches.

Important Screening Distinctions for 2026

• OIG does not state that every provider is universally required by federal statute or regulation to run the LEIE every month. OIG says providers should screen before employment/contracting and periodically thereafter, and that monthly screening best minimizes potential CMP and overpayment exposure because the LEIE is updated monthly.
• State Medicaid programs, managed-care contracts, accreditation requirements, corporate integrity obligations, or organizational policy may impose additional or more specific screening requirements. State rules should therefore be checked separately.
• OIG recommends using the LEIE as the primary source for OIG exclusions. SAM includes broader federal debarment information but should not be treated as a substitute for the LEIE.
• The CMS Preclusion List is not simply another version of the LEIE. Its direct payment consequences are tied to Medicare Advantage and Part D, and CMS makes updates available to affected plans on an approximately monthly cycle.

This webinar benefits the following organizations:

• Hospitals and health systems
• Physician practices and medical groups
• Home health and hospice organizations
• Skilled nursing and post-acute providers
• Behavioral health organizations
• Pharmacies and pharmacy networks
• Third-party billing companies
• Credentialing and provider-enrollment organizations
• Medicare and Medicaid participating providers and suppliers
• Healthcare staffing organizations
• Managed care and Medicare Advantage organizations
• Vendors and contractors supporting federally reimbursed healthcare services

Primary Regulatory / Program Relevance

• HHS Office of Inspector General (OIG)
• OIG List of Excluded Individuals/Entities (LEIE)
• Centers for Medicare & Medicaid Services (CMS)
• CMS Preclusion List
• Medicare Advantage (Part C)
• Medicare Part D
• State Medicaid exclusion and provider-screening requirements, where applicable

Who should attend?

• Chief Compliance Officers
• Compliance Officers and Compliance Directors
• Internal Auditors and Healthcare Compliance Auditors
• Chief Executive Officers and Chief Operating Officers
• Chief Financial Officers
• General Counsel and Healthcare Attorneys
• HR Directors and HR Compliance Professionals
• Credentialing Directors and Specialists
• Provider Enrollment Leaders
• Revenue Cycle Directors and Billing Managers
• Medical Billing Companies and Third-Party Billing Leaders
• Procurement and Vendor Management Leaders
• Risk Management Professionals
• Practice Administrators and Medical Practice Managers
• Home Health and Hospice Administrators
• Pharmacy Compliance Leaders
• Medicare Advantage / Part D Compliance Professionals
• Contract Management and Staffing Oversight Professionals